{
    "medicine_id": "2b8fbabe3f0b2d461f3413929381d67d35c014e3",
    "platform_id": "DB04209",
    "metadata": {
        "name": "Dequadin 15 mg Tablet",
        "composition": "15 mg Dequalinium",
        "clinical_particulars": {
            "therapeutic_indications": "Effective local treatment as vaginal tablets for infections such as fluor vaginalis bacterial vaginosis aerobic vaginitis vulvo vaginal candidiasis and trichomoniasis Used as a topical antimicrobial agent",
            "contraindications": {
                "disease": "The oral LD50 value of dequalinium chloride for mouse is 300mg kg Lethal dose LD50 of a single intraperitoneal administration in a murine model system is 18 3 mg kg The majority of the adverse reactions of vaginal dequalinium tablets in clinical studies about 90 were local reactions particularly vaginal discharge vulvovaginal pruritus and a vaginal burning sensation Dequalinuim is not reported to possess embryo foetal toxicity at clinically relevant doses",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Dequalinium is an antimicrobial against Gram negative and positive bacteria yeast and protozoa It primarily mediates this action by increasing the cell permeability with subsequent loss of enzyme activity under a rapid bactericidal and fungicidal action The enzymatic inactivation initially might be reversible but becomes irreversible after a longer contact time between the drug and bacteria A19280 The bactericidal and fungicidal effect of dequalinium chloride has been demonstrated to occur within 30 60 min A19294 Dequalinium targets a broad spectrum of microorganisms including aerobic and anaerobic bacteria as well as Candida species",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}